In line with these findings, one hospital-based study reported higher plasma IL-22 levels in patients with type 2 diabetes than in healthy controls or individuals with metabolically healthy obesity [9]. The gene discussed is IL22; the disease is obesity due to melanocortin 4 receptor deficiency.